ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,958Medicare Part D Prescriptions Filled, Including Refills

Rank: 283 out of 1107

$649K Total Retail Price of All Prescriptions

Rank: 260 out of 1107

211 Patients Receiving at Least One Drug in Part D
97%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 211 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

32% of this provider’s 211 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

1% of this provider’s 10,722 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

52 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
WARFARIN SODIUM 545 517 1 15
HYDROCODONE-ACETAMINOPHEN 461 443 S3 2 1
NAMENDA 451 446 3 42
DONEPEZIL HCL 363 357 4 32
OMEPRAZOLE 347 334 5 4
LEVOTHYROXINE SODIUM 266 248 6 3
AMLODIPINE BESYLATE 246 246 7 6
FUROSEMIDE 213 213 8 7
SIMVASTATIN 212 188 9 5
METOPROLOL TARTRATE 207 199 10 10
POTASSIUM CHLORIDE 206 206 11 14
IPRATROPIUM-ALBUTEROL 196 196 12 154
NYSTATIN 168 164 13 110
DIVALPROEX SODIUM 162 162 14 96
ISOSORBIDE MONONITRATE ER 161 161 15 34
LISINOPRIL 160 154 16 2
MIRTAZAPINE 153 153 17 61
POLYETHYLENE GLYCOL 3350 145 144 18 46
ESCITALOPRAM OXALATE 134 124 19 82
RANITIDINE HCL 133 127 20 21
CYMBALTA 118 118 21 50
EXELON 117 117 22 103
SERTRALINE HCL 104 97 23 20
CITALOPRAM HBR 101 101 24 17
TAMSULOSIN HCL 94 94 25 30
GALANTAMINE HBR 91 91 26 277
GABAPENTIN 89 65 27 9
ZOLPIDEM TARTRATE 89 83 27 22
XOPENEX 87 87 10 29 357
LEVOFLOXACIN 80 79 30 71
METOPROLOL SUCCINATE 79 79 31 16
CLOTRIMAZOLE-BETAMETHASONE 77 77 32 198
ATENOLOL 74 74 33 19
DIGOXIN 72 72 34 52
PANTOPRAZOLE SODIUM 72 72 34 30
SPIRONOLACTONE 71 71 36 72
LACTULOSE 69 69 37 89
LIDODERM 69 69 37 140
FAMOTIDINE 69 69 37 111
NOVOLIN R 69 68 37 187
SEROQUEL 65 65 41 182
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 63 42 88
LEXAPRO 64 61 42 219
RISPERIDONE 62 62 44 79
GLIPIZIDE 59 59 45 64
CARVEDILOL 57 51 46 27
QUETIAPINE FUMARATE 56 56 47 94
ARICEPT 55 55 48 289
PROMETHAZINE HCL 52 52 R 49 44
PLAVIX 51 51 50 39
PREDNISONE 51 51 50 40
NOVOLOG 50 50 52 127
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.